ClinicalTrials.gg
Not yet recruitingNCT07534150Updated Apr 16, 2026

Blood Flow Restriction Parameters and Lower Limb Function in Older Adults With Dynapenia

An interventional study of Blood Flow Restriction and Conventional Resistance Training in Dynapenia, sponsored by Kaohsiung Medical University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 55 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-16.

Sponsored by Kaohsiung Medical University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
720
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Study summary

The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. This phase aims to examine LOP values and their potential influencing factors, including demographic and physiological characteristics such as age, height, body weight, blood pressure, waist circumference, body fat percentage, medical history of chronic diseases, and habitual physical activity. Muscle-related assessments will include skeletal muscle mass, thigh and calf circumference, handgrip strength, and lower limb muscle strength. Functional performance will be evaluated using the five-times sit-to-stand test and the SARC-F questionnaire for sarcopenia risk screening. LOP of the lower limbs will be measured using a BFR cuff system combined with a laboratory-developed blood flow detection device. The study will further investigate whether LOP values are associated with the aforementioned factors.

The objective of the second year is to utilize high-density surface electromyography (dEMG) to analyze the electrophysiological characteristics of muscle contraction in individuals with sarcopenia under varying BFR pressures and resistance intensities. This includes examining motor unit recruitment patterns and recruitment thresholds, with the goal of identifying effective and appropriate BFR exercise parameters for this population.

The objective of the third year is to investigate the effects of lower limb BFR combined with resistance training on functional performance in individuals with dynapenia. Building upon the findings from the first year, this phase will implement BFR resistance training interventions and evaluate both short-term and long-term effects. Through an experimental design, the study will assess changes in body composition, muscle strength, and functional performance following a four-month intervention, along with a three-month follow-up period, to determine whether participants can improve to a healthy status and maintain these improvements over time.

02

Conditions studied

  • Dynapenia

Keywords

  • Blood Flow Restriction Training
  • Elderly
  • Dynapenia
  • Occlusion Pressure
03

In context

Lead sponsor

Kaohsiung Medical University is the lead sponsor of 56 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 55 years and older.
  • No regular physical activity within the past three months, defined as exercising no more than twice per week.
  • No cognitive impairment and able to follow exercise and assessment instructions.

Exclusion criteria

Exclusion Criteria

  • Have to exercise, such as severe musculoskeletal problems, osteoporosis, deep vein thrombosis, or coagulation disorders.
  • Have comorbid conditions that are severe or end-stage, such as stroke diagnosed by a neurologist, diabetes with severe complications (e.g., retinopathy), or cardiovascular disease including heart failure, coronary ischemia, or arrhythmia.
  • Have high-risk factors for exercise, such as uncontrolled hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg), angina or chest tightness during exercise, or deep vein thrombosis.
  • Have a history of hematologic disorders or are currently taking blood-related medications, such as hormones or anticoagulants.
  • Are expected to move out of the local community within three months.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
720 participants (estimated)

Study arms

  • Experimental
    Blood Flow Restriction Group (BFR)

    Receive low intensity lower limb resistance training with the use of Blood Flow Restriction

    Device: Blood Flow Restriction

  • Active comparator
    Conventional Resistance Training Group (CRT)

    Receive traditional high intensity lower-limb resistance training

    Other: Conventional Resistance Training

Interventions

  • DeviceBlood Flow Restriction

    Leg Press Training. two sessions per week. BFR cuff set at 50-65% of Limb Occlusion Pressure, three sets of 30-15-15 repetitions in a total of 3 sets. Intensity set at 20-30% of 1RM. Device: Delfi Personal Tourniquet System (PTS)

  • OtherConventional Resistance Training

    Leg Press Training, two sessions per week, three sets per session. 8-10 repetitions each set with intensity ranging from 60%-75%.

06

What researchers measure

Primary outcomes

  1. Baseline Data

    Collect data on participants' demographics including gender, age, education level, living situation, lifestyle habits (such as alcohol consumption and smoking), and health status with chronic disease history. Daily activity patterns are assessed using the International Physical Activity Questionnaire - Short Self-Administered Taiwanese Chinese Version (IPAQ), which surveys participants' activities of different intensities over the past seven days.

    Time frame: week0(pre-intervention), week16(post-intervention)

  2. Muscle Strength

    Hand Grip Strength measured via a Dynamometer, recorded in kg Knee Extensor Strength measured via a hand-held Dynamometer

    Time frame: week0(pre-intervention), week16(post-intervention)

  3. Muscle Function: The Short Physical Performance Battery (SPPB)

    The Short Physical Performance Battery (SPPB) evaluates lower extremity function through three tasks: standing balance (side-by-side, semi-tandem, tandem), 4-meter gait speed, and a 5-repetition chair stand test. Each task is scored from 0 (inability to complete) to 4 (best performance). The three component scores are summed for a total score ranging from 0 to 12, with higher scores indicating better physical performance. Unit of Measure: scores on a scale (points)

    Time frame: week0(pre-intervention), week16(post-intervention)

  4. Height

    Standard Measurements: Height, recorded in centimeters.

    Time frame: week0(pre-intervention), week16(post-intervention)

  5. Weight

    Standard Measurements: Weight, recorded in kilograms(kg)

    Time frame: week0(pre-intervention), week16(post-intervention)

  6. BMI

    weight and height will be combined to report BMI in kg/m\^2

    Time frame: week0(pre-intervention), week16(post-intervention)

  7. Blood Pressure

    Measured via a Blood Pressure Monitor, Systolic Blood Pressure and Diastolic Blood Pressure will be recorded in mmHg

    Time frame: week0(pre-intervention), week16(post-intervention)

  8. Circumferences

    Waist line, Thigh Circumference, Calf Circumference will be using standard tape measure and recorded in centimeter(cm)

    Time frame: week0(pre-intervention), week16(post-intervention)

  9. SARC-F Questionnaire

    The questionnaire consists of five items, each scored 0, 1, or 2, with higher scores indicating greater difficulty for the participant. The total score ranges from 0 to 10. The items assess difficulty in Strength, Assistance in walking, Rising from a chair, Climbing, and Fall. A SARC-F score greater than 4 indicates a population at risk for sarcopenia.

    Time frame: week0(pre-intervention)

  10. Electromyography(EMG)

    Electromyography characteristics of Vastus Lateralis and Vastus Medialis

    Time frame: week0(pre-intervention), week16(post-intervention)

  11. Limb Occlusion Pressure(LOP)

    Measured in a seated position with the knee fully extended, using a laboratory-developed blood flow occlusion detection system. During the measurement, a manually inflated pressure cuff was placed at the proximal thigh near the hip joint, while a photoplethysmography (PPG) sensor and a temperature sensor were positioned over the dorsalis pedis artery on the anterior aspect of the ankle to detect distal PPG and temperature signals.

    Time frame: week0(pre-intervention)

  12. Skeletal muscle mass

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in kilograms(kg)

    Time frame: week0(pre-intervention), week16(post-intervention)

  13. Body fat percentage

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in percentage(%)

    Time frame: week0(pre-intervention), week16(post-intervention)

  14. Estimated appendicular skeletal muscle mass

    Measured by Bioelectrical Impedance Analysis(BIA), recorded in kilograms(kg)

    Time frame: week0(pre-intervention), week16(post-intervention)

07

Study locations

1 site
  • Sports Biomechanics Laboratory
    Kaohsiung City, No. 100, Shiquan 1st Rd., Sanmin Dist., Kaohsiung City 807, Taiwan
08

References and documents

Individual participant data

Plan to share: Yes — The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. The objective of the second year is to utilize high-density surface electromyography (dEMG) to analyze the electrophysiological characteristics of muscle contraction in individuals with sarcopenia under varying BFR pressures and resistance intensities. The objective of the third year is to investigate the effects of lower limb BFR combined with resistance training on functional performance in individuals with dynapenia.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: De-identified individual participant data (IPD) and supporting information will be available starting 2 years after the publication of the primary study results and will remain accessible for 5 years.

Access criteria: The related supporting documents will only be made available to qualified researchers affiliated with academic institutions, medical organizations, or public health agencies. Applicants must submit a detailed research proposal and ethical approval document, and access will be granted only upon approval.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Dec 2028, 32 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2026
First posted
Apr 16, 2026
StartEst.
Apr 2026
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Apr 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07534150
Lead sponsor
Kaohsiung Medical University
Responsible party
Chih-Yu Lin (Principal Investigator, Kaohsiung Medical University) — Principal investigator
First posted
Apr 16, 2026
Start date
Apr 2026 (estimated)
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Apr 16, 2026

Study contacts

LIN C Y Kaohsiung Medical University, Master
Contact
jojojeff0205@gmail.com
+8867-3121101 ext. #2646 #614
GUO L Y Professor and Dean of the College of Health Science, Departmen, Ph.D.
study chair · Department of Sports Science, Kaohsiung Medical University, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion